Literature DB >> 9158512

A high-risk group for prostatism: a population-based epidemiological study in Korea.

E Lee1, M S Park, C Shin, H Lee, K Yoo, Y Kim, Y Shin, H Y Paik, C Lee.   

Abstract

OBJECTIVE: To evaluate the effect of sociodemographic, dietary and physical factors on prostatism in Korean men aged 50 and over. SUBJECTS AND METHODS: A community-based cross-sectional epidemiological study was performed in Yonchon County, Korea. The Korean version of the International Prostate Symptom Score (IPSS) was used to assess the severity of prostatism. Data on occupation, marital status, education, smoking habits, alcohol intake, daily consumption of nutrients, body mass index, abdominal circumference, waist-to-hip ratio, blood pressure, serum glucose, cholesterol, triglyceride and high-density lipoprotein (HDL) levels were analysed. The age-adjusted relative risk of these factors was calculated for moderate to severe prostatism (IPSS > or = 8). A multivariate analysis of all significant factors was performed to examine the joint effect of risk factors.
RESULTS: Of 514 subjects, 119 (23.2%) had moderate to severe prostatism, the risk for which was related to age and alcohol consumption; waist-to-hip ratio (which represents the degree of abdominal obesity) and the serum level of HDL showed a biphasic association with prostatism in the multivariate analysis.
CONCLUSION: In addition to previously reported risk factors, these data suggest that there might be an association between the development of prostatism and abnormal lipid metabolism.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9158512     DOI: 10.1046/j.1464-410x.1997.00149.x

Source DB:  PubMed          Journal:  Br J Urol        ISSN: 0007-1331


  12 in total

1.  Towards the prevention and management of prostatic diseases in Nigeria: a framework.

Authors:  Chukwunonso Ecc Ejike
Journal:  Malays J Med Sci       Date:  2011-07

Review 2.  Benign prostatic hyperplasia: dietary and metabolic risk factors.

Authors:  H Nandeesha
Journal:  Int Urol Nephrol       Date:  2008-02-02       Impact factor: 2.370

Review 3.  Cholesterol and benign prostate disease.

Authors:  Michael R Freeman; Keith R Solomon
Journal:  Differentiation       Date:  2011-08-20       Impact factor: 3.880

4.  Serum lipid levels in benign prostatic hyperplasia.

Authors:  Murat Lekili; Talha Müezzinoğlu; Bekir Sami Uyanik; Coşkun Büyüksu
Journal:  World J Urol       Date:  2006-02-28       Impact factor: 4.226

5.  The prevalence of lower urinary tract symptoms in Austrian males and associations with sociodemographic variables.

Authors:  G Haidinger; S Madersbacher; T Waldhoer; G Lunglmayr; C Vutuc
Journal:  Eur J Epidemiol       Date:  1999-09       Impact factor: 8.082

Review 6.  Changing therapeutic regimens in benign prostatic hyperplasia. Clinical and economic considerations.

Authors:  H J Stoevelaar; J McDonnell
Journal:  Pharmacoeconomics       Date:  2001       Impact factor: 4.981

Review 7.  Insulin: a novel agent in the pathogenesis of prostate cancer.

Authors:  Hanumanthappa Nandeesha
Journal:  Int Urol Nephrol       Date:  2008-07-30       Impact factor: 2.370

Review 8.  Epidemiology of lower urinary tract symptoms: emphasis on the status in Korea.

Authors:  Hakmin Lee; Seong Jin Jeong
Journal:  Korean J Urol       Date:  2014-05-12

9.  Rapid increase of health care utilization and cost due to benign prostatic hyperplasia in Korean men: retrospective population-based analysis using the Health Insurance Review and Assessment service data.

Authors:  Hwancheol Son; Juhyun Park; Sang Hoon Song; Jung Yoon Kang; Sung Kyu Hong; Hyun Moo Lee; Sun-Hee Kim; Byung-Joo Park; Hyung-Lae Lee; Kyung Seop Lee
Journal:  J Korean Med Sci       Date:  2015-01-21       Impact factor: 2.153

10.  Comparative analysis of benign prostatic hyperplasia management by urologists and nonurologists: a Korean nationwide health insurance database study.

Authors:  Juhyun Park; Young Ju Lee; Jeong Woo Lee; Tag Keun Yoo; Jae Il Chung; Seok-Joong Yun; Jun Hyuk Hong; Seong Il Seo; Sung Yong Cho; Hwancheol Son
Journal:  Korean J Urol       Date:  2015-03-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.